Dollars for Profs

Dig Into University Researchers' Outside Income and Conflicts of Interest

Published Dec. 6, 2019

This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.

Financial doc
Filing Type

Conflict of Interest

Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.

Should you be removed from our database? Contact us at [email protected]. Read more below.

Kimberly Kelly

University of Virginia, Department: Biomedical Engineering

Should you be removed from our database? Contact us at [email protected]. Read more below.

Disclosed Conflict of Interest with

iTi Health, Inc.

Disclosed Value
Listed Reason
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)

This NIH project will make use of a targeted peptide sequence which has been licensed to the named entity, iTi Health, Inc. It was our determination that the financial interest is in an entity whose financial interest could be affected by the research; i.e., the SFI is related to the funded research. Further, we determined that this SFI could potentially effect the design, conduct or reporting of this research, and thus, a financial conflict of interest exists.

Listed Research Project
Highly Specific and Efficient Vectors for Targeting Pancreatic Cancer

The overall goal of this proposal is to develop a new drug delivery system that is targeted to a novel cancer tag will be developed for use in treating pancreatic cancer. We will do this by making small particles that are capable of delivering drugs and are targeted to the cancer through the use of tags that identify the cancer. The developed targeted drug delivery system will ultimately be used for delivery of numerous cell-killing agents specifically to cancer cells, potentially improving patient life.

Filed on September 17, 2014.

Tell us what you know about Kimberly Kelly's disclosure

We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?

If you see an error in the database or a reason we should not disclose a record, please contact us at [email protected] and we'll evaluate it on a case-by-case basis.
Sources: National Institutes of Health, public records requests filed at multiple public state universities

Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.

Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.

ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page